PMCB — Pharmacyte Biotech Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedMicro CapNeutral

Annual balance sheet for Pharmacyte Biotech, fiscal year end - April 30th, USD millions except per share, conversion factor applied.

	2020 April 30th	2021 April 30th	2022 April 30th	2023 April 30th	2024 April 30th
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	0.895	2.2	85.4	68	50.2
Prepaid Expenses
Total Current Assets	1.04	2.28	85.5	68.1	50.4
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	6.17	7.4	90.6	73.3	59.9
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	1.03	0.725	0.704	0.587	7.42
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	1.08	0.725	0.704	0.587	20.4
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	5.09	6.68	89.9	72.7	39.5
Total Liabilities & Shareholders' Equity	6.17	7.4	90.6	73.3	59.9
Total Common Shares Outstanding
Total Preferred Shares Outstanding